Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 115806812 | 11580681 | 2 | F | 20150914 | 20160329 | 20150930 | 20160401 | PER | PHEH2015US018731 | NOVARTIS | 55.67 | YR | M | Y | 0.00000 | 20160401 | CN | COUNTRY NOT SPECIFIED | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 115806812 | 11580681 | 1 | PS | COSENTYX | SECUKINUMAB | 1 | Subcutaneous | 300 MG, QW | S0008A | 125504 | 300 | MG | INJECTION | /wk | |||||
| 115806812 | 11580681 | 2 | SS | COSENTYX | SECUKINUMAB | 1 | Subcutaneous | UNK UNK, QMO | S0008A | 125504 | INJECTION | /month |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 115806812 | 11580681 | 1 | Psoriasis |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 115806812 | 11580681 | Drug ineffective | |
| 115806812 | 11580681 | Local swelling | |
| 115806812 | 11580681 | Peripheral swelling |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 115806812 | 11580681 | 1 | 20150804 | 0 | ||
| 115806812 | 11580681 | 2 | 20151101 | 20160329 | 0 |